Toyoda H - Search Results

1

Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update.

Kudo M, Kawamura Y, Hasegawa K, Tateishi R, Kariyama K, Shiina S, Toyoda H, Imai Y, Hiraoka A, Ikeda M, Izumi N, Moriguchi M, Ogasawara S, Minami Y, Ueshima K, Murakami T, Miyayama S, Nakashima O, Yano H, Sakamoto M, Hatano E, Shimada M, Kokudo N, Mochida S, Takehara T. Kudo M, et al. Among authors: toyoda h. Liver Cancer. 2021 Jun;10(3):181-223. doi: 10.1159/000514174. Epub 2021 May 19. Liver Cancer. 2021. PMID: 34239808 Free PMC article. Review.

2

Changes in the characteristics and survival rate of hepatocellular carcinoma from 1976 to 2000: analysis of 1365 patients in a single institution in Japan.

Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Hayashi K, Honda T, Kitabatake S, Kuzuya T, Nonogaki K, Kasugai T, Shimizu J. Toyoda H, et al. Cancer. 2004 Jun 1;100(11):2415-21. doi: 10.1002/cncr.20289. Cancer. 2004. PMID: 15160346 Free article.

3

Staging hepatocellular carcinoma by a novel scoring system (BALAD score) based on serum markers.

Toyoda H, Kumada T, Osaki Y, Oka H, Urano F, Kudo M, Matsunaga T. Toyoda H, et al. Clin Gastroenterol Hepatol. 2006 Dec;4(12):1528-36. doi: 10.1016/j.cgh.2006.09.021. Clin Gastroenterol Hepatol. 2006. PMID: 17162244

4

Role of tumor markers in assessment of tumor progression and prediction of outcomes in patients with hepatocellular carcinoma.

Toyoda H, Kumada T, Osaki Y, Oka H, Kudo M. Toyoda H, et al. Hepatol Res. 2007 Sep;37 Suppl 2:S166-71. doi: 10.1111/j.1872-034X.2007.00181.x. Hepatol Res. 2007. PMID: 17877479

5

Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC.

Toyoda H, Kumada T, Kaneoka Y, Osaki Y, Kimura T, Arimoto A, Oka H, Yamazaki O, Manabe T, Urano F, Chung H, Kudo M, Matsunaga T. Toyoda H, et al. J Hepatol. 2008 Aug;49(2):223-32. doi: 10.1016/j.jhep.2008.04.013. Epub 2008 May 23. J Hepatol. 2008. PMID: 18571271

6

Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.

Kudo M, Izumi N, Kokudo N, Matsui O, Sakamoto M, Nakashima O, Kojiro M, Makuuchi M; HCC Expert Panel of Japan Society of Hepatology. Kudo M, et al. Dig Dis. 2011;29(3):339-64. doi: 10.1159/000327577. Epub 2011 Aug 9. Dig Dis. 2011. PMID: 21829027

7

FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma.

Arao T, Ueshima K, Matsumoto K, Nagai T, Kimura H, Hagiwara S, Sakurai T, Haji S, Kanazawa A, Hidaka H, Iso Y, Kubota K, Shimada M, Utsunomiya T, Hirooka M, Hiasa Y, Toyoki Y, Hakamada K, Yasui K, Kumada T, Toyoda H, Sato S, Hisai H, Kuzuya T, Tsuchiya K, Izumi N, Arii S, Nishio K, Kudo M. Arao T, et al. Among authors: toyoda h. Hepatology. 2013 Apr;57(4):1407-15. doi: 10.1002/hep.25956. Epub 2013 Feb 11. Hepatology. 2013. PMID: 22890726

8

Baseline factors and early viral response (week 4) to antiviral therapy with peginterferon and ribavirin for predicting sustained virologic response in patients infected with hepatitis C virus genotype 1: a multicenter study.

Toyoda H, Kumada T, Shimada N, Takaguchi K, Ide T, Sata M, Ginba H, Matsuyama K, Izumi N. Toyoda H, et al. J Med Virol. 2013 Jan;85(1):65-70. doi: 10.1002/jmv.23428. J Med Virol. 2013. PMID: 23154876

9

Significance of a reduction in HCV RNA levels at 4 and 12 weeks in patients infected with HCV genotype 1b for the prediction of the outcome of combination therapy with peginterferon and ribavirin.

Toyoda H, Kumada T, Shimada N, Takaguchi K, Ide T, Sata M, Ginba H, Matsuyama K, Izumi N. Toyoda H, et al. BMC Infect Dis. 2012 Nov 27;12:324. doi: 10.1186/1471-2334-12-324. BMC Infect Dis. 2012. PMID: 23181537 Free PMC article. Clinical Trial.

10

Diagnostic accuracy for macroscopic classification of nodular hepatocellular carcinoma: comparison of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and angiography-assisted computed tomography.

Tada T, Kumada T, Toyoda H, Ito T, Sone Y, Okuda S, Ogawa S, Igura T, Imai Y. Tada T, et al. Among authors: toyoda h. J Gastroenterol. 2015 Jan;50(1):85-94. doi: 10.1007/s00535-014-0947-x. Epub 2014 Feb 22. J Gastroenterol. 2015. PMID: 24563123

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,439 results

Search Page